Related Experiment Video
Updated: Apr 20, 2026
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
IBS: biomarkers for IBS: ready for prime time?
1Department of Medical and Surgical Sciences, University of Bologna, St Orsola-Malpighi Hospital, Building No. 5, Via Massarenti, 9, I-40138 Bologna, Italy.
Molecular mechanisms are increasingly linked to gut dysfunction and symptoms in Irritable Bowel Syndrome (IBS). This growing evidence provides a foundation for identifying novel IBS biomarkers.
Area of Science:
- Gastroenterology
- Molecular Biology
- Biomarker Discovery
Background:
- Irritable Bowel Syndrome (IBS) is a common functional gastrointestinal disorder.
- The underlying causes of IBS, including gut dysfunction and symptom generation, are complex and not fully understood.
- Emerging evidence suggests a significant role for molecular mechanisms in IBS pathophysiology.
Purpose of the Study:
- To highlight the accumulating evidence linking molecular mechanisms to IBS.
- To emphasize the potential for discovering IBS biomarkers based on this evidence.
Main Methods:
- Review of current scientific literature on IBS molecular mechanisms.
- Analysis of studies investigating gut dysfunction and symptom generation in IBS patients.
Main Results:
- Growing body of evidence implicates specific molecular pathways in IBS.
- These pathways contribute to gut dysmotility, visceral hypersensitivity, and altered gut-brain axis signaling.
Conclusions:
- Molecular mechanisms are fundamental to understanding IBS.
- The identified molecular targets represent promising avenues for the development of diagnostic and therapeutic IBS biomarkers.
More Related Videos
08:42Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
09:44Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
Published on: September 11, 2012
Related Concept Videos
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:23Irritable Bowel Syndrome
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...